ANTWERP, Belgium and SINGAPORE, March 1, 2011 /PRNewswire/ -- Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunities globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.
Sponsors, start-ups and academic projects with commercial potential will now be able to approach a single platform for the full development of biomedical devices from pre-clinical evaluation to late-stage clinical trials. Medical device companies and start-ups find it increasingly difficult to build such services in-house and seek partners to enable commercialization of their pipeline products. This strategic alliance allows them to address their needs on a single, global platform.
Because of the intrinsic embedment of the alliance across Europe, Asia and the US, sponsors will have multiple locations to conduct translational research.
With Innoheart's state-of-the-art imaging, pre-clinical expertise and research infrastructure in Asia combined with genae's expertise, quality and reliability, and world-class global network, the alliance will offer services that address the complete clinical research trajectory.
Collaborative objectives will include but are not limited to the expansion of services across the value chain of biomedical device R&D from pre-clinical to clinical evaluation, sharing of core lab services, particularly in relation to implantation, evaluation,disease model preparation and pivotal clinical trials.
Innoheart is a pre-clinical contract research organization providing GLP-ready in-life studies in biomedical devices, biologics and medical implants. The company is based in Singapore, an Asian hub for medical device development and is the first dedicated facility of its kind in the Asia Pacific region. The facility boasts state-of-the-art imaging, research equipment and qualified staff. Innoheart provides high quality turn-key study management of in-life studies facilitating a quick and accurate evaluation.
genae associates is a privately held NV/SA with principal offices in Antwerp, Belgium. genae Americas is a privately held Delaware Corporation with principal offices in Cleveland, OH. genae is ISO 9001 certified as CRO, Core Laboratories and Services Provider for the Medical Industries. These services include Clinical Data Management, Safety Management, Electronic Data Capture (EDC), Statistical Analysisand Training & Education.
SOURCE genae associates